Literature DB >> 10417752

Gelatinase activity in keloids and hypertrophic scars.

A N Neely1, C E Clendening, J Gardner, D G Greenhalgh, G D Warden.   

Abstract

Keloids and hypertrophic scars are characterized by excessive deposition of collagen, which may result from insufficient protein degradation. Little is known about the levels of two gelatinases, matrix metalloproteinase-2 (72 kD type IV collagenase) and matrix metalloproteinase-9 (matrix metalloproteinase-9; 92 kD type IV collagenase) in these abnormal scars. The purpose of this study was to determine levels of these proteinases in tissue from hypertrophic scars, keloids, and donor skin. Ten hypertrophic scar samples, 9 keloid samples, and 10 donor skin samples were frozen, pulverized, homogenized, clarified by centrifugation, and analyzed for matrix metalloproteinases by quantitative zymography. Identity of matrix metalloproteinases was determined using a conditioned media reference standard, molecular weight ladders, and Western blotting. Levels of matrix metalloproteinase-9 activity were very low or undetectable in all samples. However, matrix metalloproteinase-2 activity was significantly elevated in keloids and hypertrophic scars vs. donor samples: 2.6 and 3.9-fold increases for latent matrix metalloproteinase-2, 7.8 and 6.9-fold increases for active matrix metalloproteinase-2, respectively. We conclude that little matrix metalloproteinase-9 activity (the gelatinase involved in early tissue repair) is present in keloids and hypertrophic scars, while matrix metalloproteinase-2 activity (the gelatinase involved in prolonged tissue remodeling) is present in donor skin and is significantly increased in hypertrophic scars and keloids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417752     DOI: 10.1046/j.1524-475x.1999.00166.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  19 in total

Review 1.  Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.

Authors:  Gerd G Gauglitz; Hans C Korting; Tatiana Pavicic; Thomas Ruzicka; Marc G Jeschke
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

Review 2.  Collagenase and surgical disease.

Authors:  Timothy R Donahue; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Hernia       Date:  2006-12       Impact factor: 4.739

3.  siRNA knockdown of tissue inhibitor of metalloproteinase-1 in keloid fibroblasts leads to degradation of collagen type I.

Authors:  Masayo Aoki; Koichi Miyake; Rei Ogawa; Teruyuki Dohi; Satoshi Akaishi; Hiko Hyakusoku; Takashi Shimada
Journal:  J Invest Dermatol       Date:  2013-09-16       Impact factor: 8.551

Review 4.  Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring.

Authors:  Meilang Xue; Christopher J Jackson
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

5.  MMP- and TIMP-secretion by human cutaneous keratinocytes and fibroblasts--impact of coculture and hydration.

Authors:  Andrea A Tandara; Thomas A Mustoe
Journal:  J Plast Reconstr Aesthet Surg       Date:  2010-06-09       Impact factor: 2.740

6.  Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin.

Authors:  Y P Han; T L Tuan; M Hughes; H Wu; W L Garner
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

7.  Treatment of hypertrophic scars and keloids by fractional carbon dioxide laser: a clinical, histological, and immunohistochemical study.

Authors:  O A Azzam; D A Bassiouny; M S El-Hawary; Z M El Maadawi; R M Sobhi; M S El-Mesidy
Journal:  Lasers Med Sci       Date:  2016-01       Impact factor: 3.161

8.  Wound Healing Versus Regeneration: Role of the Tissue Environment in Regenerative Medicine.

Authors:  Anthony Atala; Darrell J Irvine; Marsha Moses; Sunil Shaunak
Journal:  MRS Bull       Date:  2010-08-01       Impact factor: 6.578

9.  A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection.

Authors:  Angels Natividad; Graham Cooke; Martin J Holland; Matthew J Burton; Hassan M Joof; Kirk Rockett; Dominic P Kwiatkowski; David C W Mabey; Robin L Bailey
Journal:  BMC Med Genet       Date:  2006-04-27       Impact factor: 2.103

10.  Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1.

Authors:  Constantin C Chipev; Marcia Simon
Journal:  BMC Dermatol       Date:  2002-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.